XML 22 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
Class A ordinary shares
Common stock
CNY (¥)
shares
Class B ordinary shares
Common stock
CNY (¥)
shares
Additional Paid-in Capital [Member]
CNY (¥)
Statutory Reserve [Member]
CNY (¥)
Accumulated deficit [Member]
CNY (¥)
Accumulated Other Comprehensive income [Member]
CNY (¥)
Shareholders' Equity [Member]
CNY (¥)
Non-controlling Interest [Member]
CNY (¥)
CNY (¥)
shares
USD ($)
shares
Opening Balance at Jun. 30, 2019 ¥ 2,712,773   ¥ 250,624,798 ¥ 4,148,929 ¥ (164,780,885) ¥ 2,909,936 ¥ 95,615,551 ¥ 11,085,429 ¥ 106,700,980 $ 15,930,932
Opening Balance (in shares) at Jun. 30, 2019 [1] 4,361,634                  
Capital contribution in non-controlling interests               405,000 405,000 60,468
Share issuance ¥ 1,701,005   24,065,350       25,766,355   25,766,355 3,847,033
Share issuance (in shares) [1] 2,591,112                  
Restricted shares issued for management ¥ 163,455   7,781,380       7,944,835   7,944,835 1,186,200
Restricted shares issued for management (in shares) [1] 250,086                  
Restricted shares issued for service     33,927       33,927   33,927 5,065
Net income (loss) for the year         (19,246,701)   (19,246,701) (875,903) (20,122,604) (3,004,395)
Foreign currency translation adjustment           (84,205) (84,205)   (84,205) (12,572)
Ending Balance at Jun. 30, 2020 ¥ 4,577,233   282,505,455 4,148,929 (184,027,586) 2,825,731 110,029,762 10,614,526 120,644,288 18,012,731
Ending Balance (in shares) at Jun. 30, 2020 [1] 7,202,832                  
Capital contribution receivable due from non-controlling Interest               (50,000,000) (50,000,000) (7,465,225)
Step acquisition of FGS               34,790,000 34,790,000 5,194,303
Capital contribution in non-controlling interests               50,000 50,000 7,465
Share issuance ¥ 3,579,783   77,511,358       81,091,141   81,091,141 12,107,272
Share issuance (in shares) [1] 6,014,102                  
Share issuance for warrants exercised ¥ 1,563,589   19,566,446       21,130,035   21,130,035 3,154,809
Share issuance for warrants exercised (in shares) [1] 2,591,112                  
Proceeds from Pre-founded warrants ¥ 791,658   29,484,911       30,276,569   30,276,569 4,520,428
Proceeds from Pre-founded warrants (in shares) [1] 1,330,000                  
Restricted shares issued for management ¥ 112,839   6,027,198       6,140,037   6,140,037 916,735
Restricted shares issued for management (in shares) [1] 188,662                  
Issuance of common share in exchange of shares of Starry, net of issuance costs ¥ 187,133   27,488,317       27,675,450   27,675,450 4,132,069
Issuance of common share in exchange of shares of Starry, net of issuance costs (in shares) [1] 316,345                  
Share issuance for convertible notes redemption ¥ 5,528,591   36,907,078       42,435,669   42,435,669 6,335,836
Share issuance for convertible notes redemption (in shares) [1] 9,225,338                  
Net income (loss) for the year         (22,832,734)   (22,832,734) (3,034,094) (25,866,828) (3,862,028)
Foreign currency translation adjustment           (850,895) (850,895)   (850,895) (127,042)
Ending Balance at Jun. 30, 2021 ¥ 16,340,826   479,490,763 4,148,929 (206,860,320) 1,974,836 295,095,034 (7,579,568) 287,515,466 42,927,353
Ending Balance (in shares) at Jun. 30, 2021 [1] 26,868,391                  
Capital contribution in non-controlling interests               1,130,000 1,130,000 168,714
Restricted shares issued for management ¥ 76,804 ¥ 2,408,498 36,778,183       39,263,485   ¥ 39,263,485 $ 5,862,215
Restricted shares issued for management (in shares) [1] 128,672 4,100,000                
Share issuance for convertible notes redemption (in shares)                 9,225,338 9,225,338
Share issuance for Pre-founded warrants ¥ 859,413   (766,092)       93,321   ¥ 93,321 $ 13,933
Share issuance for Pre-founded warrants (in share) [1] 1,470,000                  
Cancellation of ordinary shares issued to Starry Lab ¥ (187,133)   (27,488,317)       (27,675,450)   (27,675,450) (4,132,069)
Cancellation of ordinary shares issued to Starry Lab (in shares) [1] (316,345)                  
Restricted shares issued for services (in shares) [1] 1,550,000                  
Restricted shares issued for service ¥ 911,760   8,024,159       8,935,919   8,935,919 1,334,173
Net income (loss) for the year         95,586,795   95,586,795 (1,297,400) 94,289,395 14,077,831
Foreign currency translation adjustment           9,332,625 9,332,625   9,332,625 1,393,403
Ending Balance at Jun. 30, 2022 ¥ 18,001,670 ¥ 2,408,498 ¥ 496,038,696 ¥ 4,148,929 ¥ (111,273,525) ¥ 11,307,461 ¥ 420,631,729 ¥ (7,746,968) ¥ 412,884,761 $ 61,645,553
Ending Balance (in shares) at Jun. 30, 2022 [1] 29,700,718 4,100,000                
[1] Retrospectively restated for effect of share split on December 27, 2019 and change in class of shares on April 5, 2021.